Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
Pro Medicus Dividend Announcement
• Pro Medicus announced a semi annually dividend of A$0.22 per ordinary share which will be made payable on 2024-09-26. Ex dividend date: 2024-09-04
• Pro Medicus annual dividend for 2024 was A$0.40
• Pro Medicus annual dividend for 2023 was A$0.30
• Pro Medicus's trailing twelve-month (TTM) dividend yield is 0.21%
• Pro Medicus's payout ratio for the trailing twelve months (TTM) is 44.15%
• Pro Medicus's dividend growth over the last five years (2018-2023) was 37.97% year
• Pro Medicus's dividend growth over the last ten years (2013-2023) was 31.10% year
Pro Medicus Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-04 | A$0.22 | semi annually | 2024-09-26 |
2024-02-29 | A$0.18 | semi annually | |
2023-09-06 | A$0.17 | semi annually | 2023-09-28 |
2023-03-02 | A$0.13 | semi annually | 2023-03-24 |
2022-09-08 | A$0.12 | semi annually | 2022-09-30 |
2022-03-03 | A$0.10 | semi annually | 2022-03-25 |
2021-09-09 | A$0.08 | semi annually | 2021-10-01 |
2021-03-04 | A$0.07 | semi annually | 2021-03-19 |
2020-09-10 | A$0.06 | semi annually | 2020-10-02 |
2020-03-05 | A$0.06 | semi annually | 2020-03-20 |
2019-09-12 | A$0.04 | semi annually | 2019-10-04 |
2019-03-12 | A$0.03 | semi annually | 2019-05-17 |
2019-03-07 | A$0.04 | semi annually | 2019-03-22 |
2018-09-06 | A$0.04 | semi annually | 2018-09-27 |
2018-03-08 | A$0.03 | semi annually | 2018-03-23 |
2017-09-07 | A$0.03 | semi annually | 2017-09-28 |
2017-03-09 | A$0.01 | semi annually | 2017-03-24 |
2016-09-08 | A$0.01 | semi annually | 2016-09-29 |
2016-03-10 | A$0.01 | semi annually | 2016-03-24 |
2015-09-09 | A$0.01 | semi annually | 2015-10-02 |
2015-03-04 | A$0.01 | semi annually | 2015-03-20 |
2014-09-10 | A$0.01 | semi annually | 2014-10-03 |
2014-03-03 | A$0.01 | semi annually | 2014-03-21 |
2013-09-09 | A$0.01 | semi annually | 2013-10-04 |
2013-03-04 | A$0.01 | semi annually | 2013-03-22 |
Pro Medicus Dividend per year
Pro Medicus Dividend growth
Pro Medicus Dividend Yield
Pro Medicus current trailing twelve-month (TTM) dividend yield is 0.21%. Interested in purchasing Pro Medicus stock? Use our calculator to estimate your expected dividend yield:
Pro Medicus Financial Ratios
Pro Medicus Dividend FAQ
Other factors to consider when evaluating Pro Medicus as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Pro Medicus stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Pro Medicus's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Pro Medicus publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Pro Medicus distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Pro Medicus are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Pro Medicus sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Pro Medicus distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Pro Medicus declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Pro Medicus's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Pro Medicus's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.